Left Bundle Branch Pacing Versus Conventional Pacing in Atrioventricular Block

NCT ID: NCT05129098

Last Updated: 2023-10-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-13

Study Completion Date

2022-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Recently, the concept of physiological pacing has emerged in the clinical practice, in an attempt to prevent the deteriorating effects of right ventricular pacing in the long-term. Left bundle branch pacing seems to be a safe procedure with promising results that may prevent intraventricular dyssynchony compared with the conventional right ventricular pacing.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this prospective, randomized study the outcomes regarding echocardiographic indices of dyssynchrony in left bundle branch versus conventional right ventricular pacing in patients with atrioventricular node disease will be compared In recent years, His pacing has demonstrated better results regarding resynchronization compared to conventional biventricular pacing in trials of 3D mapping. However, technical difficulties that relate to unstable lead positioning or inability in succeeding low pacing threshold have led to low success rates. An alternative site of physiological pacing that could possibly overcome these issues, while maintaining ventricular synchrony is left bundle branch pacing. The lead implantation of LBB pacing is performed using the Select Secure (3830) pacing lead. The lead is screwed into the interventricular septum, until left bundle branch pacing is achieved. The randomized patients 24 hours after the procedure are echocardiographically evaluated and indices of mechanical dyssynchrony are recorded. Follow-up is conducted at 3 months, 6 months and one year post-procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrioventricular Nodal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Left Bundle Branch Pacing

Implantation of a left bundle branch lead via sheath, to perform left bundle branch pacing

Group Type EXPERIMENTAL

Left bundle branch pacing lead (Select Secure 3830 lead)

Intervention Type DEVICE

Implantation of a left bundle branch pacing lead via sheath

Conventional Right Venticular Pacing

The ventricular lead will be implanted in the right ventricle in the conventional way

Group Type ACTIVE_COMPARATOR

Right ventricular active fixation lead

Intervention Type DEVICE

Active fixation lead (standard)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Left bundle branch pacing lead (Select Secure 3830 lead)

Implantation of a left bundle branch pacing lead via sheath

Intervention Type DEVICE

Right ventricular active fixation lead

Active fixation lead (standard)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age\>18 years old
* Patients with atrioventricular block and EF\>50% with a predicted ventricular pacing rate\>20%
* Patients with intraventricular septal diameter\>8mm
* Written informed consent

Exclusion Criteria

* Indication for CRT or ICD device
* Patients with no subclavian approach, who are candidates for leadless devices
* Presence of severe tricuspid regurgitation
* Patients who are candidates for implantation from the right side, as currently the provided tools for left bundle branch pacing fascilitate only left sided pacemaker implantations
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital of Patras

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Georgios Leventopoulos

Principa Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Georgios Leventopoulos, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Patras

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital of Patras

Pátrai, Rion, Greece

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

251/10-05-21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.